Husain-Syed, Faeq
Ronco, Claudio
Wiech, Thorsten
Hecker, Matthias
Seeger, Werner
Article History
Received: 20 January 2021
Accepted: 15 April 2021
First Online: 30 April 2021
Declarations
:
: Not applicable.
: Not applicable.
: FH-S and MH declare no competing interests. CR reports support for acting as an advisory board member for ASAHI, Baxter, GE, Jafron, and Medtronic, and speaker’s fees from Astute, bioMérieux, B. Braun, Cytosorbents, ESTOR, FMC, and Toray, all unrelated to this editorial. TW received speaker’s fees from Novartis and is supported by the Bundesministerium für Bildung und Forschung (BMBF), Netzwerk Universitätsmedizin (DEFEAT PANDEMIcs) unrelated to this editorial. WS report personal fees for consulting from Bayer Pharma, Liquidia Technologies, and United Therapeutics all unrelated to this editorial.